BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11495027)

  • 1. T-helper cell response to woodchuck hepatitis virus antigens after therapeutic vaccination of chronically-infected animals treated with lamivudine.
    Hervás-Stubbs S; Lasarte JJ; Sarobe P; Vivas I; Condreay L; Cullen JM; Prieto J; Borrás-Cuesta F
    J Hepatol; 2001 Jul; 35(1):105-11. PubMed ID: 11495027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens.
    Lu M; Klaes R; Menne S; Gerlich W; Stahl B; Dienes HP; Drebber U; Roggendorf M
    J Hepatol; 2003 Sep; 39(3):405-13. PubMed ID: 12927927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic effects of woodchuck hepatitis virus surface antigen vaccine in combination with antiviral therapy: breaking of humoral and cellular immune tolerance in chronic woodchuck hepatitis virus infection.
    Menne S; Roneker CA; Tennant BC; Korba BE; Gerin JL; Cote PJ
    Intervirology; 2002; 45(4-6):237-50. PubMed ID: 12566706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid emergence of a viral resistant mutant in WHV chronically infected woodchucks treated with lamivudine and a pre-S/S CHO-derived hepatitis B virus vaccine.
    D'Ugo E; Kondili LA; Canitano A; Catone S; Giuseppetti R; Gallinella B; Palmieri G; Orobello S; Argentini C; Glück R; Rapicetta M
    Vaccine; 2007 Jun; 25(26):4895-902. PubMed ID: 17531355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.
    Glebe D; Lorenz H; Gerlich WH; Butler SD; Tochkov IA; Tennant BC; Cote P; Menne S
    J Virol; 2009 Feb; 83(4):1579-91. PubMed ID: 19052077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.
    Zhou T; Guo JT; Nunes FA; Molnar-Kimber KL; Wilson JM; Aldrich CE; Saputelli J; Litwin S; Condreay LD; Seeger C; Mason WS
    J Virol; 2000 Dec; 74(24):11754-63. PubMed ID: 11090175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute resolving woodchuck hepatitis virus (WHV) infection is associated with a strong cytotoxic T-lymphocyte response to a single WHV core peptide.
    Frank I; Budde C; Fiedler M; Dahmen U; Viazov S; Lu M; Dittmer U; Roggendorf M
    J Virol; 2007 Jul; 81(13):7156-63. PubMed ID: 17459928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR; Korba BE; Cote PJ; Toshkov I; Delaney WE; Gerin JL; Tennant BC
    Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.
    Lu M; Hilken G; Kruppenbacher J; Kemper T; Schirmbeck R; Reimann J; Roggendorf M
    J Virol; 1999 Jan; 73(1):281-9. PubMed ID: 9847331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12.
    Crettaz J; Otano I; Ochoa-Callejero L; Benito A; Paneda A; Aurrekoetxea I; Berraondo P; Rodríguez-Madoz JR; Astudillo A; Kreppel F; Kochanek S; Ruiz J; Menne S; Prieto J; Gonzalez-Aseguinolaza G
    J Virol; 2009 Mar; 83(6):2663-74. PubMed ID: 19116251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunity.
    Wang J; Gujar SA; Cova L; Michalak TI
    J Virol; 2007 Jan; 81(2):903-16. PubMed ID: 17079319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression reactivates viral replication long after resolution of woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Butler SD; Toshkov IA; Gerin JL; Tennant BC
    Hepatology; 2007 Mar; 45(3):614-22. PubMed ID: 17326155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
    Daffis S; Balsitis S; Chamberlain J; Zheng J; Santos R; Rowe W; Ramakrishnan D; Pattabiraman D; Spurlock S; Chu R; Kang D; Mish M; Ramirez R; Li L; Li B; Ma S; Hung M; Voitenleitner C; Yon C; Suresh M; Menne S; Cote P; Delaney WE; Mackman R; Fletcher SP
    Hepatology; 2021 Jan; 73(1):53-67. PubMed ID: 32246499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
    Korba BE; Cote P; Hornbuckle W; Schinazi R; Gerin JL; Tennant BC
    Antiviral Res; 2000 Jan; 45(1):19-32. PubMed ID: 10774587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model.
    Lu M; Roggendorf M
    Intervirology; 2001; 44(2-3):124-31. PubMed ID: 11509873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against woodchuck hepatitis virus (WHV) infection by gene gun coimmunization with WHV core and interleukin-12.
    García-Navarro R; Blanco-Urgoiti B; Berraondo P; Sánchez de la Rosa R; Vales A; Hervás-Stubbs S; Lasarte JJ; Borrás F; Ruiz J; Prieto J
    J Virol; 2001 Oct; 75(19):9068-76. PubMed ID: 11533170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced antiviral benefit of combination therapy with lamivudine and alpha interferon against WHV replication in chronic carrier woodchucks.
    Korba BE; Cote P; Hornbuckle W; Schinazi R; Gangemi JD; Tennant BC; Gerin JL
    Antivir Ther; 2000 Jun; 5(2):95-104. PubMed ID: 10971862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.